Format

Send to

Choose Destination
See comment in PubMed Commons below
J Heart Lung Transplant. 2015 Mar;34(3):362-8. doi: 10.1016/j.healun.2014.08.020. Epub 2014 Aug 28.

Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance.

Author information

1
Division of Pulmonary, Critical Care, Sleep Medicine and Allergy, The Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts. Electronic address: hfarber@bu.edu.
2
ICON Clinical Research, San Francisco, California.
3
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota; Division of Cardiovascular Diseases, Allegheny General Hospital, Pittsburgh, Pennsylvania.
4
Division of Pulmonary and Critical Care, Baylor College of Medicine, Houston, Texas.
5
Actelion Pharmaceuticals US Inc, South San Francisco, California.
6
Division of Cardiovascular Diseases, Allegheny General Hospital, Pittsburgh, Pennsylvania.

Abstract

BACKGROUND:

Clinical studies of pulmonary arterial hypertension have used the change in the 6-minute walk distance (6MWD) as a clinical end point; however, its association with survival outcomes has not been well established. In this analysis, we examined the prognostic value of the baseline 6MWD, absolute thresholds of the 6MWD, and change in the 6MWD.

METHODS:

Patients in the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) with 6MWD at enrollment, with or without a follow-up assessment within the first year of observation, were included. Kaplan-Meier survival estimates were computed for sub-sets with baseline 6MWD results that were above or below all possible thresholds and for sub-sets with a change in the 6MWD that was 10 percentage points above or below all possible thresholds, including improvement thresholds and worsening thresholds. Multivariable Cox regression models assessed the effect of improvement and worsening in the 6MWD on 1-year survival, adjusted for baseline factors.

RESULTS:

One-year survival estimates were higher for patients with a baseline 6MWD above vs below a threshold, although no specific threshold was more prognostic than another. In a model adjusted for the baseline 6MWD and risk score, worsening of the 6MWD over time significantly predicted decreased survival, but improvement in the 6MWD did not affect survival.

CONCLUSIONS:

No 6MWD improvement threshold carries particular prognostic value. Improvement in the 6MWD was not associated with survival, but worsening of the 6MWD was strongly and significantly associated with poor prognosis.

KEYWORDS:

6-minute walk distance; prognostic value; pulmonary arterial hypertension; surrogate end points; survival outcomes

PMID:
25312386
DOI:
10.1016/j.healun.2014.08.020
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center